Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
about
Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic researchGeneration of a New Model Rat: Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1 Toxicity.Low-Dose Dose-Response for In Vitro Nrf2-ARE Activation in Human HepG2 CellsGenetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout miceInfluence of aflatoxin B1 on copy number variants in human leukocytes in vitroContributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents.Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.Reassessment of MTBE cancer potency considering modes of action for MTBE and its metabolites.CDDO and Its Role in Chronic Diseases.The KEAP1-NRF2 System in Cancer.Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxinExpression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposureProtective and Detoxifying Effects Conferred by Dietary Selenium and Curcumin against AFB1-Mediated Toxicity in Livestock: A Review.HAfTs are novel lncRNA transcripts from aflatoxin exposure.Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im.Pharmacogenomics of chemically distinct classes of Keap1-Nrf2 activators identify common and unique gene, protein, and pathway responses in vivo.Dual Role of Dietary Curcumin Through Attenuating AFB1-Induced Oxidative Stress and Liver Injury via Modulating Liver Phase-I and Phase-II Enzymes Involved in AFB1 Bioactivation and Detoxification.
P2860
Q26774851-96330DD2-7287-4FE8-B116-DDF758D39D02Q32872076-96F92AE1-0635-483F-9194-EB8D5E927A94Q33641296-63D44B28-4E32-4370-B151-C557954BAEEEQ33779962-4EE5A44D-0F80-4F18-8A50-DEAA9DBF71C1Q35503885-F4F99C1F-16C3-4463-9FD8-07385B701A11Q36759955-0C0D5F07-2BFF-4504-92D5-BB2520616F1CQ36863232-0B6ACAAA-78B7-4E06-AD1C-19A5C5BDAC88Q38594604-01315CF8-D155-465D-91FF-0010B7D6B358Q38807055-9B85A825-619F-4A8B-B4F6-2DB4456130C0Q39317112-0442DCA3-1E5C-443A-A9B4-BAE4EAFDC948Q40692505-70E1E754-2A15-4ACE-9865-A3B6A09E5E0BQ41931500-9183A99E-7E4C-450F-83B9-717B8A556506Q47232167-89C220E2-B7E2-49B3-BD78-7313D146FB38Q47558825-71BCC407-45A5-4C06-826A-5E5F69C45B46Q47755684-3B05CE34-7B87-448B-B4C3-59D8E405956DQ48218461-7BD0EE68-8A5A-4A80-B562-6AA8D8BD0AC1Q49789719-09E35697-B325-42A1-ACB2-EC4C26194DD8Q54992543-69BE6D82-045A-4469-8D31-87AE722979C2
P2860
Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Complete protection against af ...... e, and genotoxicity threshold.
@ast
Complete protection against af ...... e, and genotoxicity threshold.
@en
type
label
Complete protection against af ...... e, and genotoxicity threshold.
@ast
Complete protection against af ...... e, and genotoxicity threshold.
@en
prefLabel
Complete protection against af ...... e, and genotoxicity threshold.
@ast
Complete protection against af ...... e, and genotoxicity threshold.
@en
P2093
P2860
P1476
Complete protection against af ...... re, and genotoxicity threshold
@en
P2093
Bill D Roebuck
John D Groopman
Michael B Sporn
Natalie M Johnson
Patricia A Egner
Ryan S Wible
Thomas R Sutter
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0430
P577
2014-03-24T00:00:00Z